US5349085AExpiredUtility

X-ray contrast agents

87
Assignee: NYCOMED IMAGING ASPriority: Nov 8, 1982Filed: Oct 13, 1992Granted: Sep 20, 1994
Est. expiryNov 8, 2002(expired)· nominal 20-yr term from priority
C07C 233/12C07C 233/00
87
PatentIndex Score
50
Cited by
14
References
1
Claims

Abstract

Compounds of the general formula: ##STR1## (where R is a group --CH(CH 2 OH) 2 or --CH 2 CH(OH)CH 2 OH and A is a group --CH 2 CH(OH)CH 2 -- or --CH 2 CH(OH)CH(OH)CH 2 --) possess a package of favourable parameters which render them of particular use not only in all forms of intravascular visualisation but also in myelography. The compounds are prepared by reaction of an appropriate 5-acetylamino-N,N'-bis(hydroxypropyl)-2,4,6-triiodoisophthalamide with an agent effective to introduce the appropriate hydroxyalkylene group such as for example epichlorohydrin or 1,4-dichloro-2,3-dihydroxybutane.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. 1,3-bis(acetylamino)-N,N'-bis[3,5-bis(2,3-dihydroxypropylaminocarbonyl)-2,4,6-triiodophenyl]-2-hydroxypropane.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.